317 related articles for article (PubMed ID: 22974093)
1. Data quality at the Icelandic Cancer Registry: comparability, validity, timeliness and completeness.
Sigurdardottir LG; Jonasson JG; Stefansdottir S; Jonsdottir A; Olafsdottir GH; Olafsdottir EJ; Tryggvadottir L
Acta Oncol; 2012 Sep; 51(7):880-9. PubMed ID: 22974093
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness.
Bray F; Parkin DM
Eur J Cancer; 2009 Mar; 45(5):747-55. PubMed ID: 19117750
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness.
Parkin DM; Bray F
Eur J Cancer; 2009 Mar; 45(5):756-64. PubMed ID: 19128954
[TBL] [Abstract][Full Text] [Related]
4. Data quality at the Bulgarian National Cancer Registry: An overview of comparability, completeness, validity and timeliness.
Dimitrova N; Parkin DM
Cancer Epidemiol; 2015 Jun; 39(3):405-13. PubMed ID: 25914137
[TBL] [Abstract][Full Text] [Related]
5. Completeness and timeliness: Cancer registries could/should improve their performance.
Zanetti R; Schmidtmann I; Sacchetto L; Binder-Foucard F; Bordoni A; Coza D; Ferretti S; Galceran J; Gavin A; Larranaga N; Robinson D; Tryggvadottir L; Van Eycken E; Zadnik V; Coebergh JW; Rosso S
Eur J Cancer; 2015 Jun; 51(9):1091-8. PubMed ID: 24393522
[TBL] [Abstract][Full Text] [Related]
6. Quality measures of the population-based Finnish Cancer Registry indicate sound data quality for solid malignant tumours.
Leinonen MK; Miettinen J; Heikkinen S; Pitkäniemi J; Malila N
Eur J Cancer; 2017 May; 77():31-39. PubMed ID: 28350996
[TBL] [Abstract][Full Text] [Related]
7. [Relation of breast cancer tumour stage and the degree of registration in a population-based cancer registry].
Katalinic A; Holzmann M; Kunze U
Gesundheitswesen; 2003; 65(8-9):509-15. PubMed ID: 14505270
[TBL] [Abstract][Full Text] [Related]
8. Data quality at population-based cancer registries in Colombia.
Cendales R; Pardo C; Uribe C; López G; Yepez MC; Bravo LE
Biomedica; 2012; 32(4):536-44. PubMed ID: 23715229
[TBL] [Abstract][Full Text] [Related]
9. Data quality at the Singapore Cancer Registry: An overview of comparability, completeness, validity and timeliness.
Fung JW; Lim SB; Zheng H; Ho WY; Lee BG; Chow KY; Lee HP
Cancer Epidemiol; 2016 Aug; 43():76-86. PubMed ID: 27399312
[TBL] [Abstract][Full Text] [Related]
10. [The importance of the common cancer registry for the identification of cancer cases in the EPIC Potsdam-study -- results of the first record linkage].
Bergmann MM; Noethlings U; Eisinger B; Streller B; Quehl A; Walter D; Lahmann PH; Boeing H
Gesundheitswesen; 2004; 66(8-9):475-81. PubMed ID: 15372347
[TBL] [Abstract][Full Text] [Related]
11. Quality, comparability and methods of analysis of data on childhood cancer in Europe (1978-1997): report from the Automated Childhood Cancer Information System project.
Steliarova-Foucher E; Kaatsch P; Lacour B; Pompe-Kirn V; Eser S; Miranda A; Danzon A; Ratiu A; Parkin DM
Eur J Cancer; 2006 Sep; 42(13):1915-51. PubMed ID: 16919762
[TBL] [Abstract][Full Text] [Related]
12. Comparability of colorectal cancer survival data in three European population-based registries.
Monnet E; Faivre J; Raymond L; Garau I
Eur J Cancer Prev; 1998 Apr; 7(2):127-34. PubMed ID: 9818774
[TBL] [Abstract][Full Text] [Related]
13. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964-2003 followed up to the end of 2006. Material and methods.
Engholm G; Gislum M; Bray F; Hakulinen T
Acta Oncol; 2010 Jun; 49(5):545-60. PubMed ID: 20491523
[TBL] [Abstract][Full Text] [Related]
14. Quality evaluation of national cancer registry system in Iran: study protocol.
Modirian M; Rahimzadeh S; Cheraghi Z; Khosravi A; Salimzadeh H; Kompani F; Rezaei N; Qorbani M; Delavari A; Moradi-Lakeh M; Farzadfar F
Arch Iran Med; 2014 Mar; 17(3):193-7. PubMed ID: 24621363
[TBL] [Abstract][Full Text] [Related]
15. [Index for evaluating completeness of registration in population-based cancer registries and estimation of registration rate at the Osaka Cancer Registry between 1966 and 1992 using this index].
Ajiki W; Tsukuma H; Oshima A
Nihon Koshu Eisei Zasshi; 1998 Oct; 45(10):1011-7. PubMed ID: 9893469
[TBL] [Abstract][Full Text] [Related]
16. Are survival rates for Tyrol published in the Eurocare studies biased?
Oberaigner W; Siebert U
Acta Oncol; 2009; 48(7):984-91. PubMed ID: 19714522
[TBL] [Abstract][Full Text] [Related]
17. [Central nervous system tumours in children. An evaluation of the completeness and validity of the Cancer Registry].
Thorsteinsson R; Sørensen M; Jensen TL; Bernhardtsen TM; Gjerris F; Carstensen H; Schmiegelow K; Raaschou-Nielsen O
Ugeskr Laeger; 2005 Oct; 167(40):3782-5. PubMed ID: 16221395
[TBL] [Abstract][Full Text] [Related]
18. [Completeness of the cancer registry].
Berkel J
Ned Tijdschr Geneeskd; 1989 Oct; 133(41):2027-30. PubMed ID: 2797322
[TBL] [Abstract][Full Text] [Related]
19. Cancer Incidence in Five Continents. Comparability and quality of data.
Parkin DM; Muir CS
IARC Sci Publ; 1992; (120):45-173. PubMed ID: 1284606
[No Abstract] [Full Text] [Related]
20. [The use of the Epidemiology Cancer registry Baden-Württemberg in the follow-up of the EPIC cohort].
Nagel G; Zoller D; Wiedmann T; Bussas U; El Idrissi-Lamghari C; Kneisel J; Batzler WU; Becker N
Gesundheitswesen; 2004; 66(8-9):469-74. PubMed ID: 15372346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
